Literature DB >> 6433201

The prognosis for seizure control in newly diagnosed epilepsy.

R D Elwes, A L Johnson, S D Shorvon, E H Reynolds.   

Abstract

We assessed the prognosis for seizure control in 106 patients who were referred to an adult neurology clinic with previously untreated tonic-clonic, partial, or mixed seizures and were followed prospectively for a median of 66 months (range, 6 to 96). Twenty-six patients remained completely free of seizures for as long as they were followed. Actuarial analysis showed that 35 per cent of patients could be expected to enter a seizure-free period of at least two years at the start of treatment, 73 per cent would have had a two-year seizure-free period at the end of four years, and 82 per cent would have had a two-year seizure-free period at the end of eight years. Of 79 patients whose seizures were completely controlled for at least two years, 51 subsequently remained seizure-free. If seizures continued for up to two years after the start of treatment, the probability of subsequent seizure control fell by half. The presence of partial seizures; a high frequency of tonic-clonic seizures before treatment; a neurologic, social, or psychiatric handicap; and a family history of epilepsy each indicated a worse prognosis. We conclude that the long-term pattern of seizure control is largely established during the first two years of treatment.

Entities:  

Mesh:

Year:  1984        PMID: 6433201     DOI: 10.1056/NEJM198410113111503

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  32 in total

Review 1.  Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants.

Authors:  K Wilbur; M H Ensom
Journal:  Clin Pharmacokinet       Date:  2000-04       Impact factor: 6.447

Review 2.  Changing view of prognosis of epilepsy.

Authors:  E H Reynolds
Journal:  BMJ       Date:  1990-11-17

3.  Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment.

Authors:  Marvin M Goldenberg
Journal:  P T       Date:  2010-07

4.  Refractory epilepsy: one size does not fit all.

Authors:  Jacqueline A French
Journal:  Epilepsy Curr       Date:  2006 Nov-Dec       Impact factor: 7.500

5.  Progress in the treatment of epilepsy.

Authors:  C D Binnie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-04       Impact factor: 10.154

6.  Stimulation of 5-HT1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats.

Authors:  M Gariboldi; P Tutka; R Samanin; A Vezzani
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 7.  Diagnosis and treatment of epilepsy in children and adolescents.

Authors:  L D Morton; J M Pellock
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

Review 8.  Proportional hazards (Cox) regression.

Authors:  M H Katz; W W Hauck
Journal:  J Gen Intern Med       Date:  1993-12       Impact factor: 5.128

9.  Epileptic patients refractory to drug therapy.

Authors:  L Paris; M Giardina; R Pacifici; S Pichini; P Zuccaro; G Sideri
Journal:  Ital J Neurol Sci       Date:  1991-10

Review 10.  Pharmacoresistance and the role of surgery in difficult to treat epilepsy.

Authors:  Samuel Wiebe; Nathalie Jette
Journal:  Nat Rev Neurol       Date:  2012-09-11       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.